Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phospholipovit in Combined Hyperlipidemia
NCT05742022Phase 3Completed
- Sponsor
- Institute of Biomedical Chemistry
- Start
- Jan 2016
- Primary completion
- Jun 2018
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of Phospholipovit in combined hyperlipidemia, sponsored by Institute of Biomedical Chemistry. Started Jan 2016; status: completed.
02
Drugs
Phospholipovit
03
Conditions
combined hyperlipidemia
Beyond the preview
Go deeper on NCT05742022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05742022.